E0 ConsensusPreliminaryPEM ?Review-NarrativePeer-reviewedMachine draft
Chronic fatigue syndrome: a personalized integrative medicine approach.
Brown, Benjamin I · Alternative therapies in health and medicine · 2014
Quick Summary
This review examines how treating ME/CFS with a personalized, whole-body approach might help more patients than current standard treatments. Rather than using a one-size-fits-all method, doctors could tailor treatment plans based on each patient's individual factors—such as diet, nutritional deficiencies, stress, gut health, and immune system problems. The authors suggest this personalized approach could lead to better outcomes and help identify which patients would benefit most from specific treatments.
Why It Matters
ME/CFS remains difficult to treat with existing approaches, and this framework offers hope by suggesting that tailoring treatment to each patient's specific underlying problems could improve outcomes. Understanding ME/CFS as a heterogeneous disorder with multiple potential contributing factors supports the need for personalized medicine approaches. This perspective could reshape clinical practice and guide future research toward more targeted, effective interventions.
Observed Findings
- ME/CFS is recognized as a heterogeneous disorder with diverse etiological factors and multiple pathological features
- Multiple physiological domains are potentially involved, including mitochondrial function, immune dysfunction, inflammation, oxidative stress, nutritional deficiencies, and gastrointestinal disturbances
- Current standard treatments offer only modest benefits and prognosis remains poor
- A patient-centered framework based on modifiable physiological and environmental factors is proposed as potentially more effective than one-size-fits-all approaches
- Subgroups of patients may respond preferentially to specific targeted interventions
Inferred Conclusions
- A personalized, integrative medicine approach targeting individual physiological abnormalities and environmental factors may offer more effective management than current standard treatments
- Identifying and addressing modifiable factors specific to each patient could improve clinical outcomes and prognosis
- Future research and clinical practice should adopt individualized frameworks to match treatments to patient-specific pathophysiology
- This approach may enable identification of patient subgroups most likely to benefit from specific interventions
Remaining Questions
What This Study Does Not Prove
This review does not prove that any specific integrative intervention is effective—it identifies potential avenues for further investigation. It does not establish which patients will respond to which treatments, nor does it provide evidence-based protocols ready for immediate clinical implementation. The paper proposes mechanisms and approaches worthy of study rather than confirming their clinical efficacy.
Tags
Symptom:Post-Exertional MalaiseCognitive DysfunctionUnrefreshing SleepPainFatigue
Biomarker:CytokinesMetabolomicsGene ExpressionBlood Biomarker
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- PMID
- 24445354
- Review status
- Machine draft
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 8 April 2026